Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2022 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| ZILBRYSQ | UCB Canada Inc | Marketed | Mar 17, 2025 | Marketed |
| APO-LEVOTHYROXINE | Apotex Inc | Marketed | Mar 17, 2025 | Marketed |
| ZILBRYSQ | UCB Canada Inc | Marketed | Mar 17, 2025 | Marketed |
| APO-LEVOTHYROXINE | Apotex Inc | Marketed | Mar 17, 2025 | Marketed |
| APO-LEVOTHYROXINE | Apotex Inc | Marketed | Mar 17, 2025 | Marketed |
| ZILBRYSQ | UCB Canada Inc | Marketed | Mar 17, 2025 | Marketed |
| APO-LEVOTHYROXINE | Apotex Inc | Marketed | Mar 17, 2025 | Marketed |
| JAMP LOPERAMIDE | Jamp Pharma Corporation | Marketed | Mar 14, 2025 | Marketed |
| PMS-SUGAMMADEX | Pharmascience Inc | Marketed | Mar 13, 2025 | Marketed |
| AG-IRBESARTAN | angita pharma inc. | Marketed | Mar 12, 2025 | Marketed |
| JAMP FLUCONAZOLE 150 MG | Jamp Pharma Corporation | Marketed | Mar 11, 2025 | Marketed |
| PROTEC(TINT) | supergoop, llc | Marketed | Mar 11, 2025 | Marketed |
| VEOZAH | astellas pharma canada inc | Marketed | Mar 11, 2025 | Marketed |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | formative pharma inc. | Marketed | Mar 11, 2025 | Marketed |
| APO-LEVOTHYROXINE | Apotex Inc | Marketed | Mar 7, 2025 | Marketed |
| M-TRANYLCYPROMINE | mantra pharma inc | Marketed | Mar 7, 2025 | Marketed |
| MINT-VENLAFAXINE XR | mint pharmaceuticals inc | Marketed | Mar 6, 2025 | Marketed |
| MINT-VENLAFAXINE XR | mint pharmaceuticals inc | Marketed | Mar 6, 2025 | Marketed |
| MINT-VENLAFAXINE XR | mint pharmaceuticals inc | Marketed | Mar 6, 2025 | Marketed |
| PMS-LEVODOPA-CARBIDOPA | Pharmascience Inc | Marketed | Mar 5, 2025 | Marketed |
